Last quarter (Q3 2023), Windtree Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Windtree Therapeutics's net income was $-4.42M. See Windtree Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	-	$ 0.00	$ 198.00K	$ 1.79M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ -3.56M	$ 41.33M	$ 32.26M	$ 30.32M	$ 25.09M	$ 17.98M
Operating Income	$ -11.20M	$ -41.33M	$ -32.26M	$ -30.32M	$ -24.89M	$ -16.20M
Net Non Operating Interest Income Expense	$ 265.00K	$ 56.00K	$ -23.00K	$ -3.00K	$ -342.00K	$ -1.39M
Other Income Expense	$ 6.81M	$ 6.10M	$ 45.34M	$ -2.25M	$ -2.24M	$ -2.94M
Pretax Income	$ -17.81M	$ -40.58M	$ -77.62M	$ -32.57M	$ -27.48M	$ -20.53M
Tax Provision	$ -1.37M	$ -1.37M	$ -9.99M	$ 0.00	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -16.43M	$ -9.69M	$ -67.64M	$ -32.57M	$ -27.48M	$ -34.76M
Basic EPS	$ -68.48	$ -62.23	$ -136.50	$ -2.08	$ -2.52	$ -23.22
Diluted EPS	$ -7.26	$ -62.23	$ -136.50	$ -2.08	$ -2.52	$ -23.22
Basic Average Shares	$ 10.67M	$ 630.00K	$ 495.20K	$ 15.65M	$ 10.93M	$ 1.50M
Diluted Average Shares	$ 10.04M	$ 630.00K	$ 495.20K	$ 15.65M	$ 10.93M	$ 1.50M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ -3.56M	$ 41.33M	$ 32.26M	$ 30.32M	$ 25.09M	$ 17.98M
Net Income From Continuing And Discontinued Operation	$ -24.81M	$ -9.69M	$ -67.64M	$ -32.57M	$ -27.48M	$ -20.53M
Normalized Income	$ -2.44M	$ -22.12M	-	$ -32.57M	$ -25.68M	$ -17.19M
Interest Expense	-	-	-	$ 125.00K	$ 495.00K	$ 1.41M
EBIT	$ -17.82M	$ -40.52M	$ -77.51M	$ -32.44M	$ -26.98M	$ -19.12M
EBITDA	$ -10.84M	$ -39.46M	$ -76.64M	$ -32.27M	$ -26.79M	$ -18.96M

Currency in USD

Windtree Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing